Average Co-Inventor Count = 2.84
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mannkind Corporation (22 from 278 patents)
2. Emisphere Technologies, Inc. (5 from 183 patents)
27 patents:
1. 12370137 - Method and composition for treating obesity
2. 12202807 - Methods for the synthesis of activated ethylfumarates and their use as intermediates
3. 12049453 - Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester
4. 11479535 - Methods for the synthesis of activated ethylfumarates and their use as intermediates
5. 11345668 - Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino ester
6. 10870628 - Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino ester
7. 10858325 - Methods for the synthesis of activated ethylfumarates and their use as intermediates
8. 10577331 - Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester intermediate
9. 10172850 - Substituted diketopiperazine analogs for use as drug delivery agents
10. 10071969 - Methods for the synthesis of activated ethylfumarates and their use as intermediates
11. 9944609 - Formation of N-protected bis-3,6-(4-aminobutyl)-2, 5-diketopiperazine through a cyclic alpha-N-protected amino ester
12. 9655850 - Substituted diketopiperazine analogs for use as drug delivery agents
13. 9446133 - Dry powder inhaler and system for drug delivery
14. 9220687 - Substituted diketopiperazine analogs for use as drug delivery agents
15. 9192675 - Dry powder inhaler and system for drug delivery